The ICER Collaborative addresses IPC gaps for EMS and firefighters, enhancing infection control through tailored training, advisory boards, and interagency collaboration based on year-1 findings as presented at APIC24.
The COVID-19 pandemic highlighted the essential role of prehospital care personnel, including emergency medical services (EMS) and firefighters (FFs). Traditionally, these responders have not been classified as healthcare workers, and existing infection prevention and control (IPC) training materials, such as those from the CDC’s Project First Line (PFL), may require adaptation to address their unique exposure risks and infectious disease challenges.
To address these needs, the CDC funded the establishment of the Infection Control for Emergency Responders (ICER) Collaborative and Training Hub. A multidisciplinary team was formed to conduct a needs assessment among EMS personnel and FFs to develop a multi-modal IPC training approach tailored for the prehospital setting.
Christine M. McGuire-Wolfe, PhD, CIC, CPH, an assistant professor at the University of South Florida, College of Public Health, and the director of the ICER Collaborative and Training Hub, presented this information in a poster titled “Creation of an Infection Control for Emergency Responders (ICER) Collaborative and Training Hub: Challenges, Needs, and Progress in Year 1” at the APIC 2024 Annual Conference and Exposition (APIC24) in San Antonio, Texas, held from June 3 to 5, 2024.
McGuire-Wolfe, who also teaches within infection control programs in the Global and Planetary Health Strategic Area and directs the Undergraduate Infection Control Minor, outlined the first year’s activities and findings. The team conducted interviews and focus groups with field personnel and agency representatives to identify existing IPC resources, training needs, perceptions of current training materials, willingness to engage, and trusted sources of IPC information. Comprehensive literature reviews were also undertaken, focusing on ambulance contamination, existing infection control and prevention training methods, and factors influencing the credibility of health information sources.
Key themes that emerged from these activities included:
The assessment revealed several critical needs and opportunities. Firstly, there was a clear gap in existing IPC resources specific to EMS and FFs. Responders expressed a willingness to engage with the ICER initiative, recognizing the necessity for specialized training materials and guidelines. The study also highlighted the importance of establishing strong interagency relationships before a pandemic occurs to ensure a coordinated response.
Key findings from the literature reviews supported these observations, showing significant gaps in training related to ambulance contamination and the need for trusted, credible sources of health information. These insights are instrumental in guiding the development of targeted IPC training for emergency responders.
Based on the input from field and agency representatives, the next steps for ICER include:
McGuire-Wolfe also discussed the future direction for ICER development. Moving forward, ICER will focus on developing and refining IPC training materials, establishing a robust advisory board, and fostering interagency collaboration to ensure a comprehensive and effective approach to infection control among EMS and FFs.
Establishing the ICER Collaborative and Training Hub represents a significant step towards enhancing the IPC capabilities of EMS personnel and firefighters. By addressing the unique challenges these frontline responders face, ICER aims to improve infection control practices, thereby safeguarding the health of both emergency responders and the communities they serve. The progress made in the first year lays a strong foundation for future developments, ensuring that EMS and FFs are well-equipped to handle infectious disease threats effectively.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.